Quarterly report pursuant to Section 13 or 15(d)

Marketable securities held (Details Narrative)

v2.4.0.8
Marketable securities held (Details Narrative) (USD $)
Jun. 30, 2014
Marketable Securities Held Details Narrative  
Fair value of the Call Option $ 1,386,000
Discount for lack of marketability 140,000
Fair value of escrowed Musclepharm securities net 5,719,000
Discount on escrowed Musclepharm securities 1,526,000
Fair value of escrowed Musclepharm securities gross $ 7,245,000
Non-escrowed shares price per share $ 9.00